Citations Report
Clinical Investigation : Citations & Metrics Report
Articles published in Clinical Investigation have been cited by esteemed scholars and scientists all around the world.
Clinical Investigation has got h-index 25, which means every article in Clinical Investigation has got 25 average citations.
Following are the list of articles that have cited the articles published in Clinical Investigation.
2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|
Year wise published articles |
60 | 28 | 19 | 22 | 19 |
Year wise citations received |
231 | 169 | 96 | 67 | 60 |
Journal total citations count | 2998 |
Journal impact factor | 9.25714285 |
Journal 5 years impact factor | 12.6985645 |
Journal cite score | 13.6644295 |
Journal h-index | 25 |
Journal h-index since 2018 | 20 |
Journal Impact Factor 2020 formula |
IF= Citations(y)/{Publications(y-1)+ Publications(y-2)} Y= Year |
Journal 5-year Impact Factor 2020 formula |
Citations(2016 + 2017 + 2018 + 2019 + 2020)/ {Published articles(2016 + 2017 + 2018 + 2019 + 2020)} |
Journal citescore |
Citescorey = Citationsy + Citationsy-1 + Citationsy-2 + Citations y-3 / Published articlesy + Published articlesy-1 + Published articlesy-2 + Published articles y-3 |
- Wilbers RH (2015) Plant biotechnology meets immunology: plant-based expression of immunologically relevant proteins. Wageningen University. View at Publisher | View at Google Scholar | View at Indexing
- Nam HJ, Kwon JY, Choi HY, Kang SH, Jung HS et al. (2016) Production and Purification of Recombinant Glucocerebrosidase in Transgenic Rice Cell Suspension Cultures. Applied Biochemistry and Biotechnology 5:1-5. View at Publisher | View at Google Scholar | View at Indexing
- Weaver KN, Grabowski GA, Burrow TA (2015) Velaglucerase alfa in the treatment of Gaucher disease type 1: an update. Clinical Investigation 5(6):543-9. View at Publisher | View at Google Scholar | View at Indexing
- Michaud JP, Modi R, Phillips MI. Is orphan drug pricing blowing a bubble? The unique situation of orphan drugs and why high prices will likely persist. View at Publisher | View at Google Scholar | View at Indexing
-
Wagner ES. Purificação da enzima glucocerebrosidase humana produzida no leite do primeiro clone caprino transgênico da América Latina (Master's thesis, Pontifícia Universidade Católica do Rio Grande do Sul).
View at Publisher | View at Google Scholar -
Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, et al. (2014) Platelets: still a therapeutical target for haemostatic disorders. International journal of molecular sciences 15(10):17901-19.
View at Publisher | View at Google Scholar - Geraldo RB, Sathler PC, Lourenço AL, Saito MS, Cabral LM, et al. (2014) Platelets: still a therapeutical target for haemostatic disorders. International journal of molecular sciences 15(10):17901-19. View at Publisher | View at Google Scholar | View at Indexing
- 王如èŠ, 许佩佩, 欧阳建. 生物è¯物载体在肿瘤治疗ä¸çš„ç ”ç©¶è¿›å±•. 东å—大å¦å¦æŠ¥: 医å¦ç‰ˆ. 2015(4):623-8. View at Publisher | View at Google Scholar | View at Indexing
- Iorio A, Marcucci M, Makris M (2011) Concentrateâ€Ârelated inhibitor risk: is a difference always real? Journal of Thrombosis and Haemostasis 9(11):2176-9. View at Publisher | View at Google Scholar | View at Indexing
- Ribeiro L, Bandello F, Tejerina AN, Vujosevic S, Varano M, et al. (2015) Characterization of Retinal Disease Progression in a 1-Year Longitudinal Study of Eyes With Mild Nonproliferative Retinopathy in Diabetes Type 2Identification of Retinopathy in Diabetic Patients. Investigative ophthalmology & visual science 56(9):5698-705. View at Publisher | View at Google Scholar | View at Indexing
- Silva, R., Arias, L., Nunes, S., Farinha, C., Coimbra, R., Maques, J. P., ... & Murta, J. (2021). Efficacy and safety of Intravitreal Aflibercept Vs Verteporfin Photodynamic Therapy in a Caucasian Population with Polypoidal Choroidal Vasculopathy: A Randomized Clinical Trial. Ophthalmologica. View at Publisher | View at Google Scholar | View at Indexing
- Cunha-Vaz, J., & Zrenner, E. (2011). Translational Research in Ophthalmology–A European Perspective. Journal-Translational Research in Ophthalmology–A European Perspective. View at Publisher | View at Google Scholar | View at Indexing
- Figueira, João, et al. "Ranibizumab plus panretinal photocoagulation versus panretinal photocoagulation alone for high-risk proliferative diabetic retinopathy (PROTEUS study)." Ophthalmology 125.5 (2018): 691-700. View at Publisher | View at Google Scholar | View at Indexing
- Soares ML CARACTERIZAÇÃO DAS FASES INICIAIS DA RETINOPATIA DIABÉTICA. DIAGNÓSTICO PRECOCE E BIOMARCADORES DA ATIVIDADE DA RETINOPATIA DIABÉTICA (Doctoral dissertation, Universidade de Coimbra). View at Publisher | View at Google Scholar | View at Indexing
- Benakova N (2011) Phototherapy of psoriasis in the era of biologics: still in. Acta Dermatovenerologica Croatica 19(3). View at Publisher | View at Google Scholar | View at Indexing
- Li K, Huang CC, Randazzo B, Li S, Szapary P, et al. (2016) HLA-C* 06: 02 allele and response to IL-12/23 inhibition: results from the ustekinumab phase 3 psoriasis program. Journal of Investigative Dermatology 136(12):2364-71. View at Publisher | View at Google Scholar | View at Indexing
- Sardana N, Craig TJ (2011) Recent advances in management and treatment of hereditary angioedema. Pediatrics 128(6):1173-80. View at Publisher | View at Google Scholar | View at Indexing
- Auberger J, Lass-Flörl C, Aigner M, Clausen J, Gastl G, et al. Invasive fungal breakthrough infections, fungal colonization and emergence of resistant strains in high-risk patients receiving antifungal prophylaxis with posaconazole: real-life data from a single-centre institutional retrospective observational study. Journal of Antimicrobial Chemotherapy 67(9):2268-73. View at Publisher | View at Google Scholar | View at Indexing
- Tuite NL, Lacey K (2013) Overview of invasive fungal infections. Fungal Diagnostics: Methods and Protocols :1-23. View at Publisher | View at Google Scholar | View at Indexing
- Auberger J, Greil R, Lass-Flörl C (2012) What paths are open for tackling increasing azole resistance in Aspergillus in the clinic? Expert review of anti-infective therapy 10(11):1229-31. View at Publisher | View at Google Scholar | View at Indexing
- Auberger J, Russ G, Greil R, Egle A (2011) Treatment of invasive aspergillosis in cancer patients. memo-Magazine of European Medical Oncology 4(4):266-72. View at Publisher | View at Google Scholar | View at Indexing
- Ni M, Chen Y, Fei T, Li D, Lim E, et al. (2013) Amplitude modulation of androgen signaling by c-MYC. Genes & development 27: 734-748. View at Publisher | View at Google Scholar | View at Indexing
- Lawrance IC (2014) What is left when anti-tumour necrosis factor therapy in inflammatory bowel diseases fails? World Journal of Gastroenterology: WJG 20(5):1248. View at Publisher | View at Google Scholar | View at Indexing
-
Ceva E, Moratti S (2013) Whose self-determination? Barriers to access to emergency hormonal contraception in Italy. Kennedy Institute of Ethics Journal 23(2):139-67.
View at Publisher | View at Google Scholar -
Magee M. Is Mitt Romney (Like George W. Bush) Going To Throw Science Under The Bus?
View at Publisher | View at Google Scholar -
MUCÁRZEL SUÁREZ ARANA JO, ARANCIBIA ULLOA FL (2013) Pildora del dia despues 1. Universidad, Ciencia y Sociedad. Sep:53.
View at Publisher | View at Google Scholar - Grenham S, Clarke G, Cryan JF, Dinan TG (2011) Brain–gut–microbe communication in health and disease. Frontiers in physiology 2:94 View at Publisher | View at Google Scholar | View at Indexing
- Lacombe D, Bean J, Bogaerts J, Bottomley A, Collette L, et al. (2012) 50 years of the EORTC and the central role of the EORTC Headquarters. European Journal of Cancer Supplements10:3-12 View at Publisher | View at Google Scholar | View at Indexing
- Kataoka K, Nakamura K, Caballero C, Evrard S, Negrouk A, et al. (2016) Collaboration between EORTC and JCOG—how to accelerate global clinical research partnership. Japanese Journal of Clinical Oncology View at Publisher | View at Google Scholar | View at Indexing
- Hourigan CS, Karp JE (2013) Minimal residual disease in acute myeloid leukaemia. Nature reviews Clinical oncology10:460-71 View at Publisher | View at Google Scholar | View at Indexing
- Ramos NR, Mo CC, Karp JE, Hourigan CS (2015) Current approaches in the treatment of relapsed and refractory acute myeloid leukemia. Journal of clinical medicine4:665-95 View at Publisher | View at Google Scholar | View at Indexing
- Kitson SL, Quinn DJ, Moody TS, Speed D, Watters W, et al. (2013) Antibody-Drug Conjugates (ADCs)–Biotherapeutic bullets. Chim Oggi-Chem Today31:30-6 View at Publisher | View at Google Scholar | View at Indexing
- Hourigan CS, Karp JE (2013) Personalized therapy for acute myeloid leukemia. Cancer discovery3:1336-8 View at Publisher | View at Google Scholar | View at Indexing
- Khan M, Mansoor AE, Kadia TM (2016) Future prospects of therapeutic clinical trials in acute myeloid leukemia. Future Oncology View at Publisher | View at Google Scholar | View at Indexing
- Wang R (2017) Current Standards and New Treatment Insights in HER2-Driven Metastatic Breast Disease. American Journal of Hematology/Oncology®12 View at Publisher | View at Google Scholar | View at Indexing
- Decker B, Parker HG, Dhawan D, Kwon EM, Karlins E, et al. (2015) Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer—Evidence for a relevant model system and urine-based diagnostic test. Molecular Cancer Research13:993-1002 View at Publisher | View at Google Scholar | View at Indexing
- Leow JJ, Orsola A, Chang SL, Bellmunt J (2015) A contemporary review of management and prognostic factors of upper tract urothelial carcinoma. Cancer treatment reviews41:310-9 View at Publisher | View at Google Scholar | View at Indexing
- Elyamany A, Aboziada M, Abbas H (2013) Management of bladder cancer: A literature review. International Research Journal of Medicine and Medical Sciences1:13-26 View at Publisher | View at Google Scholar | View at Indexing
- Gabril MY, Yousef GM (2014) Molecular Testing in Urothelial Tumors. In: Molecular Testing in Cancer. Springer New York View at Publisher | View at Google Scholar | View at Indexing
- Goldenberg MM (2012) Multiple sclerosis review. PT37:175-84 View at Publisher | View at Google Scholar | View at Indexing
- Liu KK, Sakya SM, O’Donnell CJ, Flick AC, Ding HX (2012) Synthetic approaches to the 2010 new drugs. Bioorganic & medicinal chemistry20:1155-74 View at Publisher | View at Google Scholar | View at Indexing
- 周丽èÂÂ, å™é»Å½, å¶海伟 (2015) 维纳å¡兰类似物的åˆæˆÂåÂŠæ´»æ€§ç ”ç©¶. 精细化工ä¸é—´ä½“45:31-5 View at Publisher | View at Google Scholar | View at Indexing
- å¶海伟, ä¿Å¾ä¼ æ˜Å½, 钟为慧, è‹Â为科 (2014) (1R, 2R)-2-((R)-3-(苄氧基) å¡咯烷基) 环己醇的åˆæˆÂç ”ç©¶. é«˜æ ¡åŒ–å¦å·¥ç¨‹å¦æŠ¥28:606-11 View at Publisher | View at Google Scholar | View at Indexing
- å¶海伟, 陈云åÂŽ, 周丽èÂÂ, ä¿Å¾ä¼ æ˜Å½ (2014) 维纳å¡兰的åˆæˆÂç ”ç©¶è¿›å±•. 有机化å¦34:1759-65 View at Publisher | View at Google Scholar | View at Indexing
- Hartmann M (2014) Clinical cancer research in transition. In: Forum 29: 485-492 View at Publisher | View at Google Scholar | View at Indexing
-
Metzger-Filho O, De Azambuja E, Bradbury I, Saini KS, Bines J, et al. (2013) Analysis of regional timelines to set up a global phase III clinical trial in breast cancer: the adjuvant lapatinib and/or trastuzumab treatment optimization experience. The oncologist18:134-40
View at Publisher | View at Google Scholar - Piccart-Gebhart MJ (2013) The 41st David A Karnofsky memorial award lecture: academic research worldwide—quo vadis?. Journal of Clinical Oncology32:347-54 View at Publisher | View at Google Scholar | View at Indexing
- Michalsen BT, Gherezghiher TB, Choi J, Chandrasena RE, Qin Z, et al. (2012) Selective estrogen receptor modulator (SERM) lasofoxifene forms reactive quinones similar to estradiol. Chemical research in toxicology25:1472-83 View at Publisher | View at Google Scholar | View at Indexing
- Mak L, Liggi S, Tan L, Kusonmano K, M Rollinger J, et al. (2013) Anti-cancer drug development: computational strategies to identify and target proteins involved in cancer metabolism. Current pharmaceutical design19:532-77 View at Publisher | View at Google Scholar | View at Indexing
- Gilbert MR (2011) Recurrent glioblastoma: a fresh look at current therapies and emerging novel approaches In: Seminars in oncology . WB Saunders View at Publisher | View at Google Scholar | View at Indexing